Itacitinib adipate is under clinical development by Incyte and currently in Phase II for Myelodysplastic Syndrome.
Emavusertib hydrochloride is under clinical development by Curis and currently in Phase II for Myelodysplastic Syndrome.
This year’s most-viewed articles and videos on myelodysplastic syndromes (MDS) explored patient quality of life, risk factors ...
Myelodysplastic syndrome (MDS) is a rare haematological cancer characterized by abnormal development and maturation (dysplasia) of immature blood cells in the bone marrow, resulting in varying ...
If you have MDS, a type of blood cancer called myelodysplastic syndrome, you’re part of a rare group of people with the diagnosis. But research is ongoing. Many clinical trials are seeking new ...
As a survivor of MDS, I’ve learned to make the best of every day and to be thankful for life. Sometimes this means avoiding ...
Luspatercept significantly improved hemoglobin levels in non-transfusion-dependent patients with lower-risk myelodysplastic ...
Anthony Olson was diagnosed with Myelodysplastic syndromes (MDS) and went on to receive chemo for almost a decade to treat ...
Madrigal Pharmaceuticals, X4 Pharmaceuticals and Day One Biopharmaceuticals secured their maiden approvals this year in metabolic dysfunction-associated steatohepatitis, WHIM syndrome and pediatric ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果